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MaOBJECTIVES The purpose of this study was to determine whether a transcatheter procedure or surgical closure offers a
better value proposition for atrial septal defect (ASD) closure.
BACKGROUND Secundum ASDs are common congenital heart defects with both transcatheter and surgical treatment
options. Although both options have been shown to have excellent results in children, the relative value of the 2 pro-
cedures is unclear.
METHODS Using data from the Pediatric Hospital Information System for 2004 to 2012, we compared the value of
transcatheter versus surgical ASD closure for children ages 1 to 17 years, with value being deﬁned as outcomes relative to
costs. Total charges for procedure-related encounters were converted to costs using hospital-speciﬁc cost-to-charge
ratios, and all costs were adjusted for inﬂation to reﬂect 2012 dollars.
RESULTS There were 4,606 transcatheter procedures and 3,159 surgeries at 35 children’s hospitals. Those undergoing
transcatheter closure were more likely to be older (5.6 years vs. 4.5 years, p < 0.0001). There was no mortality in either
group. Children with a surgical procedure had a longer length of stay (4.0 days vs. 1.5 days, p < 0.0001), were more
likely to have an infection (odds ratio: 3.73, p < 0.0001) or procedural complication (odds ratio: 6.66, p < 0.0001). Costs
for transcatheter procedure encounters were lower than costs for surgical encounters (mean of $19,128 vs. $25,359,
p < 0.0001).
CONCLUSIONS Both transcatheter and surgical ASD closure had excellent short-term outcomes, but transcatheter
procedures had lower lengths of stay, rates of infection, and complications, resulting in lower overall costs. For children
who are eligible, transcatheter ASD closure provides better short-term value than surgery. (J Am Coll Cardiol Intv
2016;9:79–86) © 2016 by the American College of Cardiology Foundation.A trial septal defects (ASD) are a common formof congenital heart disease, accounting forabout 10% of all congenital heart defects in
children (1). Secundum type ASDs are the most com-
mon variant, constituting for approximately 75% of
all ASDs.
Historically, the standard treatment for patients
with ASDs has always been surgical closure through a
median sternotomy using cardiopulmonary bypass.
This method has been proven to be safe and effective
with excellent long-term results (2,3). Since the ﬁrstm the *Division of Cardiology, Children’s Healthcare of Atlanta, Atlanta,
iversity School of Medicine, Atlanta, Georgia. The authors have report
tents of this paper to disclose.
nuscript received July 7, 2015; revised manuscript received September 4,introduction of an ASD device closure using a double-
umbrella device in 1976 by King et al. (4), trans-
catheter ASD closures have undergone tremendous
advancements and reﬁnements of device designs and
delivery techniques, and is being increasingly used in
recent years. Multiple studies have shown trans-
catheter ASD closures to be equally as safe and efﬁ-
cacious with similar outcomes when compared
with surgical ASD closures (5–11). Reported advan-
tages for device closure include better cosmetics
with avoidance of a sternotomy scar, avoidance ofGeorgia; and the yDepartment of Pediatrics, Emory
ed that they have no relationships relevant to the
2015, accepted September 8, 2015.
FIGURE 1 Exclusion/Inclusion
ABBR EV I A T I ON S
AND ACRONYMS
ASD = atrial septal defects
CI = conﬁdence interval
OR = odds ratio
PHIS = Pediatric Health
Information System
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80cardiopulmonary bypass, less post-operative
discomfort, and shorter hospital stay. In
pediatrics, studies have also shown no dif-
ference in neurodevelopmental outcomes
between the 2 treatments (12). Indeed,
transcatheter ASD closure has now become
the standard of care in adults (13).SEE PAGE 87Although both transcatheter and surgical ASD
closure appears to have equally favorable outcomes,
there is a paucity of data as to which option may
offer a better value. With the extensive use ofDiagramtranscatheter ASD closure in the current era, it is
paramount to examine its value as an important
dimension of comparative effectiveness. In fact,
the American College of Cardiology and American
Heart Association now stress the importance of
value assessments as a criterion when developing
guidelines (14). Several small, single-institutional
studies have previously reported better value of
transcatheter ASD closure when compared with
surgery (7–9,11,15). However, recent data have
shown tremendous variability in hospital and pro-
cedural costs between individual centers (16). The
only multicentered study that has addressed this
issue to date was done in adults and outside of the
United States (17).
We sought to compare the value of transcatheter
and surgical ASD closure in children in the United
States by comparing the costs and outcomes of
the respective procedures. We hypothesized that a
transcatheter option confers a better value when
compared with surgery.
METHODS
A retrospective cohort study was conducted using
data from the Pediatric Health Information System
(PHIS) database; a large, multicenter administra-
tive database (18). Data such as demographics, di-
agnoses, procedures, interventions, outcomes and
charges for all inpatient encounters are collected
from over 40 U.S. pediatric tertiary care hospitals
that are members of the Children’s Hospital Asso-
ciation. This organization provides a range of
services to its member hospitals in efforts to reduce
hospital costs, increase revenue, advance competi-
tiveness, and improve the quality of care for
children. Data quality is ensured by careful systemic
monitoring, including coding consensus meetings
bimonthly, coding consistency reviews, and quar-
terly data quality reports. It has proven itself in the
past to be a good platform for outcomes and quality
based research.
We included in our analyses all children ages 1 to 17
years that underwent either transcatheter or surgical
ASD closure from January 1, 2004, to December 31,
2012, at institutions that contributed to the PHIS
database. Hospitals were excluded if they had <5
transcatheter procedures or <5 open-heart ASD sur-
geries, or if they did not have hospital charge data
available for review. Patients were also excluded if
they were <1 year old, had presence of complex
congenital heart disease, genetic defects, or if
their date of service was not the same as their
date of admission (inpatient referral), because we
FIGURE 2 Transcatheter and Surgical ASD Closure Distribution by Hospital
ASD ¼ atrial septal defect.




(n ¼ 3,159) p Value
Age at procedure, yrs, N ¼ 7,765 5.6 (3.7–11.0) 4.5 (3.0–7.8) <0.0001
Male, N ¼ 7,765 1,693 (36.8) 1,188 (37.6) 0.45
Race, N ¼ 7,185
Asian 131 (3.1) 103 (3.5)
Black 351 (8.3) 300 (10.1) 0.03
Other 821 (19.5) 536 (18.1)
White 2,913 (69.1) 2,030 (68.4)
Comorbidities, N ¼ 7,765
Gastrointestinal 5 (0.1) 5 (0.2) 0.54
Hematologic/Immunologic 41 (0.9) 27 (0.9) 0.87
Malignancy 14 (0.3) 9 (0.3) 0.88
Metabolic 19 (0.4) 22 (0.7) 0.09
Neuromuscular 85 (1.9) 70 (2.2) 0.25
Renal 12 (0.3) 13 (0.4) 0.25
Respiratory 30 (0.7) 28 (0.9) 0.24
Any 196 (4.3) 155 (4.9) 0.17
Values are median (range) or n (%).
ASD ¼ atrial septal defect.
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81wanted to focus our study on otherwise healthy
individuals to avoid skewing our data. We then
compared the values of both the procedures, with
value in health care being deﬁned as “outcomes
relative to costs” (19).
Our primary variables were age, sex, race (White,
Black, Asian, other), concomitant comorbidities, date
of procedure, and hospital of encounter. Concomi-
tant comorbidities were determined using the deﬁ-
nition of a Pediatric Complex Condition (20). Our
primary outcomes of interest were in-hospital mor-
tality, length of stay, rates of infection, complica-
tions, and hospital charges. Infection rates and
complications were included per PHIS usage guide-
lines in a manner consistent with prior publications
(21,22). Total hospital charges for procedure-related
encounters were converted to costs using hospital-
speciﬁc cost-to-charge ratios, and all costs were
adjusted for inﬂation to reﬂect 2012 dollars. Finally,
we examined the relationship between hospital
costs and volume for both transcatheter and surgical
closure.
Statistical analyses were performed using SAS
version 9.4 (SAS Institute, Cary, North Carolina).
Statistical signiﬁcance was assessed at the 0.05 level
unless otherwise noted. Descriptive statistics were
calculated for all variables of interest and included:
medians and interquartile ranges, and counts andpercentages, when appropriate. Normality of contin-
uous variables was assessed using histograms, normal
probability plots, and the Anderson-Darling test for
normality. Characteristics of transcatheter patients
and surgery patients were compared using chi-square
tests for categorical variables or the Wilcoxon rank
TABLE 2 Odds of Any Complication and Infection for ASD Surgical Repair vs. ASD
Transcatheter Repair
Outcome Transcatheter Surgical OR (95% CI) p Value*
Procedural complication 170 (3.7) 626 (19.8) 6.66 (5.46–8.14) <0.0001
Infection 42 (0.9) 106 (3.4) 3.73 (2.51–5.54) <0.0001
Values are n (%). *Models were adjusted for race, presence of comorbidity, age at surgery, sex, and hospital. The
odds ratio (OR) and 95% conﬁdence interval (CI) were determined using transcatheter patients as the reference
group.
ASD ¼ atrial septal defect.
TABLE 3 Adjusted E
Transcatheter Repair
Outcome








Values are mean (95% CI).
log function. Model for len
hospital. Model for charge
length of stay.
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82sum test for nonnormal continuous data. When ex-
pected cell counts were small (<5), the Fisher exact
test was used in place of the chi-square test.
To account for the clustering of patients within a
hospital and to model the variation in cost and length
of stay across hospitals, we constructed mixed-effects
linear and generalized linear models with hospital as
a random intercept. Procedure type and patient
characteristics were modeled as ﬁxed effects and
included race, age, sex, presence of comorbidities,
and complication. For the cost model, procedure type
was included as a hospital-speciﬁc random effect and
length of stay was added to the model as a ﬁxed ef-
fect. In addition, model estimates were adjusted for
other patient characteristics chosen a priori that
could potentially inﬂuence the outcome. The model
adjusted odds ratios (ORs) and 95% conﬁdence in-
tervals (CIs) were determined using transcatheter
patients as the reference group. For the continuous
outcome, cost, residual errors were gauged for
normality via histograms and quantile–quantile
probability plots. Failing to meet this assumption,
cost was log-transformed and reassessed for differ-
ences between procedures. Model-based mean esti-
mates were back-transformed via exponentiation forstimates of Cost and Length of Stay for ASD Surgical Repair vs. ASD
Transcatheter Surgical p Value*
1.5 (1.4–1.6) 4.0 (3.8–4.2) <0.0001
1.2 (1.1–1.2) 3.6 (3.4–3.8) <0.0001
1.9 (1.6–2.1) 4.3 (4.1–4.6) <0.0001
$19,128 ($17,237–$21,226) $25,359 ($23,353–$27,537) <0.0001
$17,351 ($15,753–$19,111) $24,627 ($22,763–$26,646) <0.0001
$21,087 ($18,845– $23,598) $26,113 ($24,017–$29,030) <0.0001
*Mean estimates and 95% conﬁdence intervals (CI) as based on the back-transformed
gth of stay was adjusted for race, presence of comorbidity, age at surgery, sex, and
s was adjusted for race, presence of comorbidity, age at surgery, sex, hospital, andinterpretation purposes. For length of stay, we used a
log linear model, and for complication, we used a
logistic model. To determine whether hospitals
signiﬁcantly varied in their mean cost associated
with each procedure type, the mean cost was
allowed to vary randomly among hospitals using our
random-effects models. The estimated between-
hospital variance and associated standard error were
extracted from the covariance parameter estimates
based on unstructured covariance and tested for sig-
niﬁcance (against zero) using a Z-test. Additionally,
for the cost model, the variability of hospital-speciﬁc
estimates for procedure type was also tested for
signiﬁcance. Finally, we assessed the potential rela-
tionship between hospital procedural volume and
median costs for both transcatheter and surgical
closures using Spearman correlation.
RESULTS
For the period of January 1, 2004, to December 31,
2012, the PHIS database included 10,164 eligible
patients who underwent ASD closures at 45 chil-
dren’s hospitals. Of those patients, 5,572 were
transcatheter procedures and 4,592 were surgeries.
After applying the inclusion and exclusion criteria,
our data yielded 35 pediatric hospitals with 4,606
transcatheter patients and 3,159 surgery patients for
the ﬁnal analysis. A summary of patients excluded
is provided in Figure 1. The distribution of trans-
catheter and surgical volume by hospital is summa-
rized in Figure 2.
Patient characteristics are summarized in Table 1.
When comparing the variables between the 2 pro-
cedures, those undergoing transcatheter ASD closure
were more likely to be older (5.6 years vs. 4.5 years,
p < 0.0001). There was no difference in sex or
comorbidities between the 2 procedures. Although
there was a statistical signiﬁcance when comparing
racial distribution, the difference was small, with
white patients accounting for 69.1% of transcatheter
procedure and 68.4% of surgery. In regard to the
outcomes, there was no reported in-hospital mortal-
ity in both the transcatheter and surgical groups.
Children with a surgical procedure were more likely
to have an infection (OR: 3.73, p < 0.0001) and more
likely to have post-procedural complications (OR:
6.66, p < 0.0001) (Table 2). Patients who underwent a
transcatheter ASD closure also had a shorter length of
stay (1.5 days vs. 4.0 days, p < 0.0001) with less cost
when compared with surgical ASD closures (mean of
$19,128 vs. $25,359, p < 0.0001) (Table 3). Further
stratifying length of stay and cost estimates by
presence of complication, we still found that
FIGURE 3 Median Transcatheter and Surgical Cost of ASD Closure by Hospital
Upper and lower error bars indicate 25th and 75th percentiles, respectively. ASD ¼ atrial septal defect.
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83transcatheter ASD closures had shorter length of stay
(1.9 days vs. 4.3 days, p < 0.0001) and cost less (mean
of $21,087 vs. $26,113, p < 0.0001) when compared
with surgical ASD closures. The overall contribution
of complication to length of stay was 0.7 days in
both ASD closure groups. In addition, complication
increased cost by about $3,700 in the transcatheter
ASD closure group and $1,500 in the surgical ASD
closure group. The effect of complication on cost was
almost 3 times higher in the transcatheter ASD group
than surgical ASD group (p < 0.0001).
Based on the random-effects models, there was
signiﬁcant variation in hospital mean cost for each
procedure type (p < 0.001 for each type, respec-
tively). We compared the distribution of cost of both
procedures by hospital, and found no signiﬁcant
correlation between the costs of transcatheter and
surgical ASD closure, that is, although we did ﬁnd
that surgical costs were on average higher than the
transcatheter costs, the magnitude of this difference
varied by hospital, and was sometimes inverted
(Figure 3). We then tried to see whether there was an
association between the transcatheter cost and hos-
pital volume, investigating to see whether higher
volume would lower cost, and found no signiﬁcantrelationship between the cost of either procedures
and procedural volume per center (Figure 4).
DISCUSSION
In this large, multicenter, retrospective cohort study,
both transcatheter and surgical ASD closures in the
pediatric population had excellent clinical outcomes,
with no in-hospital mortality for both procedures,
although transcatheter procedure had somewhat
lower rates of complications, infections, and length of
stay. Furthermore, transcatheter closure was signiﬁ-
cantly cheaper compared to surgery. This remained
true even when factoring in cost of complications,
which is higher in the transcatheter group. With these
clinical outcomes and signiﬁcantly lower costs, the
transcatheter procedure was shown to confer better
value when compared with surgery for closure of
secundum ASD.
Although several other studies have shown similar
results previously, they were mostly small, single-
institution studies (7–9,11,15). Our study revealed
very large interinstitutional variations in hospital
charges for each procedure, with no signiﬁcant cor-
relation between the costs of transcatheter and
FIGURE 4 Median Transcatheter and Surgical Cost of ASD Closure by Patient Volume
Relationship between (A) median transcatheter cost of atrial septal defect (ASD) closure and patient volume, and (B) median surgical cost of
ASD closure and patient volume. Upper and lower error bars indicate 25th and 75th percentiles, respectively.
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84surgical ASD closure in each individual hospital.
Therefore it is important to compare costs across
several different institutions to draw meaningfulcomparisons and conclusions of the value between
the procedures. The only multicentered study in the
literature so far was performed on adults and outside
PERSPECTIVES
WHAT IS KNOWN? Previous studies have shown that both
transcatheter and surgical ASD closures in children have equally
favorable outcomes.
WHAT IS NEW? Our study showed that transcatheter ASD
closure is as safe and provides better value when compared with
surgical ASD closure, at least in the short term.
WHAT IS NEXT? The next step is to evaluate the long-term
value of these procedures.
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85the United States (17). To the best of our knowledge,
our study is the only large multicentered study
focused on addressing this issue in the pediatric
population in the United States.
The relatively lower cost of transcatheter group
likely reﬂects shorter length of hospitalization and
shorter/lack of intensive care unit stays. These lead to
a subsequent reduction of pharmacy, respiratory,
nursing, radiology, laboratory and transfusion costs
(8,9,11,15,17). Also, the steep cost of transcatheter
devices may have been compensated by the expense
of extracorporeal circulation equipment needed for
cardiac bypass (7).
Another important element that needs to be
considered is the societal burden and cost that is
incurred during the convalescent period after each
intervention. Our study has shown a signiﬁcant dif-
ference in the length of hospital stay for both pro-
cedures, 1.5 days for the interventional procedure
versus 4 days for open-heart surgery. Post-discharge,
surgical patients will need even more time at home to
recover from their sternotomy. Earlier discharge
could theoretically allow transcatheter patients and
parents to resume their normal activities much
sooner, and encourage working patients and parents
to return to work more quickly. Although the actual
dollar effects of these advantages are difﬁcult to
quantify, it deﬁnitely has a considerable economic
impact on the family and society. This increases the
relative value of transcatheter approach, and should
be factored into the decision-making process when
choosing an intervention.
STUDY LIMITATIONS. Our study, which looked into
data obtained from a large administrative database,
has its limitations. Firstly, our data are short-term
and limited to the procedural encounter. Patients
who developed complications in the mid- to long-
term periods will not be identiﬁed by our data.
However, previous studies have reported comparable
mid- to long-term outcomes between the trans-
catheter and surgical group. Mylotte et al. (17) and
Kotowycz et al. (10) looked at adults over a 5-year
period each and noted similar long-term outcomes.
Du et al. (6) looked at both children and adults, and
described no difference in the mid-term outcomes for
both surgical and transcatheter ASD closures at 1 year.
With similar mid- and long-term outcomes, the
transcatheter option would still provide a better
value on the account of lower cost. Secondly, Inter-
national Classiﬁcation of Diseases, Ninth Edition
codes from administrative databases have been vali-
dated in identifying cases of congenital heart disease,
but also result in some false positives (23,24). Becauseour study includes both diagnosis and procedural
codes, we would expect the false-positive rates to be
lower.
Another limitation to consider is that our proce-
dural cost had to be estimated using cost-to-charge
ratios to convert hospital charges to actual cost, so
our calculated costs may not be entirely accurate.
However hospital cost-to-charge ratios should affect
both transcatheter and surgical cases equally, so the
relative costs of the procedures should be the same.
Finally, as this was a nonrandomized study, there
could be some bias as to what types of procedures for
which particular patients were referred. If more
severe cases were routinely referred for surgery, this
may have a negative impact on the outcomes, costs,
and subsequent value for the surgical option. We
attempted to control for this and other potential
biases by adjusting for race, presence of comorbidity,
age at surgery, sex, and hospital. Some clinically
signiﬁcant pre-procedural data such as hemodynamic
and anatomic differences are unavailable, factors that
may affect the decision to pursue surgery versus
catheterization (25).
On the basis of our ﬁndings, we conclude that
transcatheter ASD closure is as safe and provides
better value when compared with surgical ASD
closure, at least in the short term. For children who
are eligible, these data suggest that there should
be a strong consideration for transcatheter method
when referring a patient for ASD closure. There
still remains a very important role for surgical
ASD closures, however, especially in patients with
anatomy that may not be favorable for trans-
catheter closure.
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